Impact Factor 3.675

The 2nd most cited open-access journal in Endocrinology & Metabolism

Mini Review ARTICLE

Front. Endocrinol., 14 May 2012 | https://doi.org/10.3389/fendo.2012.00063

Stereotactic neurosurgical treatment options for craniopharyngioma

  • Section of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany

Craniopharyngioma are the most common non-glial tumors in childhood. The results of different studies indicate that radical excision surgery is not an appropriate treatment strategy for childhood craniopharyngioma with hypothalamic involvement. Stereotactic neurosurgery provides save, minimal invasive and cost-efficient options in the treatment of childhood craniopharyngioma. In this review a summary of the contribution of the stereotactic neurosurgery in the interdisciplinary treatment regime of childhood craniopharyngioma will be given and discussed in detail.

Introduction

Craniopharyngiomas are the most common non-glial tumors with an incidence of 0.5–1.0 per million new patients per year, of which 30–50% occur in childhood. In children, they are often of the adamantinomatous type with cyst formations and are frequently associated with a mutation of the beta-catenin gene (Müller, 2010). These benign tumors are located in the sellar and parasellar regions and are typically semisolid, cystic, and calcifying. Compression or infiltration of the surrounding structures, such as the optic chiasm, hypothalamus, and the floor of the third ventricle, is common.

Over the last 40 years there exists an open-ended controversy concerning the best treatment for craniopharyngioma. One group favors open surgery which is in many cases associated with increased morbidity. The other group proposes minimal-invasive procedures combined with subsequent radiotherapy to minimize risk and morbidity.

Due to the high variability in the appearance of these tumors the treatment strategy must be individually tailored to the patient. Important parameters for treatment planning are the volume of the solid part of the tumor, the presence and volume of cysts, its proximity and adhesion to the hypothalamus, the compression of optical structures, the overall neuro-ophthalmological, and endocrinological state.

Microsurgical resection should be preferred when the solid part of the tumor is large and space occupying and if there is a good chance for a total resection with low risk, especially of a hypothalamic syndrome. A similar approach is also valid for many intrasellar and transsphenoidally accessible tumors. In contrast, if the solid part of the tumor is small or if there is a substantial risk for a visual or endocrinological degradation or a hypothalamic syndrome an alternative interdisciplinary approach, including stereotactic procedures, should be considered (Ostertag et al., 2003).

The stereotactic approach can facilitate the histopathological diagnosis from a stereotactic serial biopsy obtained from the solid part of the tumor or from the wall of a cyst (Tilgner et al., 2005). Furthermore, in the case of cysts, this approach can be used to evacuate the cystic parts of the lesion by aspiration or perform an internal drainage (ventriculocystostomy) by the implantation of a catheter. Cyst evacuation results in decreased compression of the surrounding structures (optical pathway, hypothalamus) and reduction in the total volume of the lesion, which prepares it for a possible subsequent, small volume, fractionated, external radiotherapy (Schubert et al., 2009; Veeravagu et al., 2010).

Stereotactic procedures are applied under general anesthesia for children, whereas juveniles and adults are mostly treated using local anesthesia (Figure 1). Optimized planning of the stereotactic approach is accomplished on a stereotactic workstation (STP, Stryker-Leibinger, Freiburg, Germany or Precisis Plus, Inomed, Emmendingen, Germany; Figure 2) based on preoperatively acquired high resolution MRI (MP-Rage post contrast and T2 – Space, 1 mm, transversal or longitudinal orientation, Avanto, Siemens, Germany,) and intraoperative computed tomography (1 or 2 mm, transversal, Somatom Plus, Siemens, Germany) following stereotactic head fixation. Image fusion is performed, which allows stereotactic planning in any imaging modality with good visualization of the tumor, cysts, calcifications, optic pathway, hypothalamus, pituitary stalk, vessels, and nerves.

FIGURE 1
www.frontiersin.org

Figure 1. (A) Child fixed in a stereotactic ring under general anesthesia in preparation for a stereotactic procedure. (B) Stereotactic aiming bow with a probe pointing to the shaved frontal entry point.

FIGURE 2
www.frontiersin.org

Figure 2. (A–D) Eleven-year-old boy with a large craniopharyngioma cyst. Planning for a stereotactic biopsy and a cyst puncture with subsequent internal drainage showing the trajectory in an approach oriented view. Stereotactic planning system: STP4 – workstation (Stryker-Leibinger, Freiburg, Germany).

A small skin incision is performed (∼12 mm), followed by a stereotactically guided burr hole. A probe with 1.4 mm diameter is advanced to the cyst, and a biopsy is taken from the cyst’s wall. Then, the content of the cyst is aspirated and the detritus is washed out by rinsing with body-temperature saline solution. The cyst is left either emptied or refilled with saline solution if a Rickham catheter is to be placed (either for inner drainage or with a subcutaneous reservoir for later transcutaneous punctures or treatment; Figure 3). The total time for the procedure is 60–90 min, followed by three to five in-patient days. Perioperative stress prophylaxis with hydrocortisone and optional single-shot antibiosis are applied. Following the procedure the liquid balance is documented in order to detect a temporary central diabetes insipidus, which would require Desmopressin substitution.

FIGURE 3
www.frontiersin.org

Figure 3. (A,B) Postoperative MRI (T1 and T2 weighted) control showing the Rickham catheter for internal drainage ending in the shrunken hypothalamic cyst.

Before making a possible catheter implantation, a preliminary intraoperative histopathological diagnosis is obtained from a stereotactic biopsy taken from the cyst wall and is confirmed by the presence of cholesterol crystals in the cyst fluid.

The stereotactic procedure can be followed by a high precision, small volume, fractionated, external radiotherapy (30–40 Gy) depending on tumor growth, patient’s age, and taking into account aspects like the possibility of genesis of secondary tumors in the low dose areas. For slow-growing craniopharyngioma there are arguments for protecting the developing brain of small children by delaying the time of irradiation to an age older than 6 years.

In the case of a tumor cyst recurrence following open resection and percutaneous irradiation some centers use local intracavitary irradiation by instillation of 32P (Zhao et al., 2010), 90Y (Blackburn et al., 1999; Kolumbán et al., 2011), colloidal 186Re (Derrey et al., 2008; Guo et al., 2010), or 198Au (Tian et al., 1992) radioisotopes to induce fibrosis in order to suppress cyst fluid production. This is done by using stereotactically implanted catheters with subcutaneous reservoirs. Other groups describe the intracystic bleomycin therapy (Hukin et al., 2007) to induce cyst sclerosis with the intent to delay the need for surgery or radiation therapy for a few years. Serious or even fatal adverse events and long-term neurotoxicity have been reported for bleomycin use (Savas et al., 2000). For these intracavitary therapies the catheter-system must first be radiologically controlled after contrast injection before initiating therapy to avoid leakage or a connection to the ventricular system, which could induce serious, adverse side effects. Brachytherapy by the stereotactic implantation of temporary 125I-seeds in the solid part of a craniopharyngioma is also a possible treatment option (Barlas et al., 2000; Schubert et al., 2009).

Stereotactic neurosurgery can deliver several options for permanent internal drainage in a multidisciplinary approach following limited resection when recurrent cysts become space occupying, compress the optical pathway, or block the foramina Monroi: The stereotactic implantation of catheters connecting the ventricular system with the cyst (Schubert et al., 2009), the stereotactically guided endoscopic fenestration of cyst walls, or a combined stereotactic/endoscopic stent-assisted ventriculocystostomy (Berlis et al., 2006). In a series of eight patients, Pettorini et al. (2009) reports the use of neuroendoscopic positioning of intracystic catheters for treatment of craniopharyngioma as being safer than stereotactic approaches. This observation could not be confirmed in our series.

Clinical Series

From 1990 to 2010, 208 (total group) stereotactic procedures in patients with craniopharyngioma were performed in the Department of Stereotactic Neurosurgery in Freiburg. Seventy of these patients were under the age of 18 (“children,” 33 male, 37 female), 138 were older (“adults,” 67 male, 71 female). Eighty-three percent (children) and 10% (adults) had treatment under general anesthesia. Sixty-one percent (children) and 60% (adults) had a cyst puncture. Twenty-one percent (children) and 43% (adults) underwent a stereotactic biopsy. Twenty-nine percent (children) and 15% (adults) underwent ventriculocystostomy by the implantation of a catheter. No procedure related lethality or permanent morbidity was observed with these patients. The patients were followed for 10.5 ± 5.3 years (median) and the 5/10-years progression-free survival was 82/80%, respectively. In the group of children, following stereotactic treatment, the patients’ vision improved in 61%, remained unchanged in 39%, and the visual field ameliorated in 75% or remained stationary (25%). While 6% experienced temporary minor visual degradation, which recovered within days, there was no permanent visual deficit due to stereotactic surgery. Following cyst drainage the endocrinological state remained unchanged in 93%. Temporary treatment with Desmopressin was necessary in 6% of the patients due to diabetes insipidus. There was no permanent, additional endocrinological deficit observed due to the stereotactic procedure (Guthoff, 2000; Ostertag et al., 2003).

In a retrospective study Schubert et al. (2009) compared three groups of children (<18 years of age) with craniopharyngioma (n = 32). The first group included patients treated with microsurgical resection. The second group underwent stereotactic cyst drainage, implantation of a Rickham catheter, and fractionated three-dimensional conformal multi-field radiotherapy with 54 Gy volume dose. The third group received various combined approaches. In this study, the 8.5-years of freedom from tumor recurrence was 24% in the resection group as compared to 71% for children with combined stereotactic and radio-therapeutic treatment (p = 0.05). There was no permanent postoperative morbidity related to stereotactic cyst puncture and drainage. Two children with preoperative visual impairment improved, the endocrinological state was constant. At last follow up, obesity was reported in four patients (24%) in the resection group as compared to one patient (14%) in the stereotactic cyst drainage group. All groups identified tumor recurrence as a criterion for a less favorable outcome. Combined stereotactic and radio-therapeutic treatment leads to good, long-term tumor control, and quality of life due to a low morbidity rate.

Discussion

Stereotactic neurosurgery offers useful minimal-invasive treatment options in the interdisciplinary treatment regime of craniopharyngioma. These options must especially be considered if the solid part of the tumor is small, if there is a hypothalamic involvement, or if the probability for a complete resection is not favorable (Yaşargil et al., 1990). The results of the Kraniopharyngeom 2000 study indicate that radical excision surgery is not an appropriate treatment strategy for childhood craniopharyngioma with hypothalamic involvement (Müller, 2010, 2011; Steňo et al., 2011).

Childhood craniopharyngiomas are a rare tumor entity. Therefore, many clinical series reported in the literature comprise only a limited number of patients (Backlund et al., 1989, n = 42; Hoffman et al., 1992, n = 50; Schubert et al., 2009, n = 32). In contrast, standardized prospective international multicenter studies, like Kraniopharyngeom 2007, which are based on a consensus of international brain tumor committees, applying identical datasets, can easily increase the cohort size, facilitate data evaluation, and can thereby advance scientific evidence (Müller, 2010).

Stereotactic biopsy can easily facilitate the histopathological diagnosis. The target volume can be significantly reduced by the evacuation and drainage of large cysts preceding fractionated external radiation therapy. Stereotactic neurosurgical methods provide safe, minimally invasive, and cost-efficient treatment options in the interdisciplinary treatment of craniopharyngioma. The final approach should be tailored and discussed in an interdisciplinary and specialized tumor board in a dedicated and experienced center before starting the treatment.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Professor H. L. Mueller for his scientific advice and the IPSEN Company for their financial support of this publication. We thank Professor M. Schumacher and his team from the Department of Neuroradiology, University Hospital Freiburg for providing excellent MRI imaging. Valuable contribution to the final manuscript was made by Dr. Robert Kirch with his diligent text work and excellent editing.

References

Backlund, E. O., Axelsson, B., Bergstrand, C. G., Eriksson, A. L., Norén, G., Ribbesjö, E., Rähn, T., Schnell, P. O., Tallstedt, L., Sääf, M., and Thorén, M. (1989). Treatment of craniopharyngiomas-the stereotactic approach in a ten to twenty-three years perspective. I. Surgical, radiological and ophthalmological aspects. Acta Neurochir. (Wien) 99, 11–19.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Barlas, O., Bayindir, C., and Can, M. (2000). Interstitial irradiation for craniopharyngioma. Acta Neurochir. (Wien) 142, 389–395.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Berlis, A., Vesper, J., and Ostertag, C. (2006). Stent placement for intracranial cysts bycombined stereotactic/endoscopic surgery. Neurosurgery 59(Suppl. 2), ONS474–ONS479; discussion ONS479–ONS480.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Blackburn, T. P., Doughty, D., and Plowman, P. N. (1999). Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br. J. Neurosurg. 13, 359–365.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Derrey, S., Blond, S., Reyns, N., Touzet, G., Carpentier, P., Gauthier, H., and Dhellemmes, P. (2008). Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63, 1045–1052; discussion 1052–1053.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Guo, C. J., Wang, Y. C., Zhou, Z. H., Zhu, J. X., Li, Z. M., and Guo, C. L. (2010). Curative effect of stereotactic 186Re endocavitary irradiation on cystic craniopharyngioma. Zhonghua Zhong Liu Za Zhi 32, 548–550.

Pubmed Abstract | Pubmed Full Text

Guthoff, R. (2000). Ophthalmologische und Endokrinologische Befunde bei Primär Microchirurgisch und bei Stereotaktisch-Radiotherapeutisch Behandelten Patienten mit Kraniopharyngeomen. Dissertation. Medizinische Fakultät, Albert-Ludwigs-Universität, Freiburg.

Hoffman, H. J., De Silva, M., Humphreys, R. P., Drake, J. M., Smith, M. L., and Blaser, S. I. (1992). Aggressive surgical management of craniopharyngiomas in children. J. Neurosurg. 76, 47–52.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Hukin, J., Steinbok, P., Lafay-Cousin, L., Hendson, G., Strother, D., Mercier, C., Samson, Y., Howes, W., and Bouffet, E. (2007). Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer 109, 2124–2131.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Kolumbán, Z., Bálint, K., and Julow, J. (2011). Shrinkage dynamics of cystic craniopharyngeomas after Yttrium-90 colloid brachytherapy. Ideggyogy. Sz. 64, 36–40.

Pubmed Abstract | Pubmed Full Text

Müller, H. L. (2010). Childhood craniopharyngioma – current concepts in diagnosis, therapy and follow-up. Nat. Rev. Endocrinol. 6, 609–618.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Müller, H. L. (2011). Consequences of craniopharyngioma surgery in children. J. Clin. Endocrinol. Metab. 96, 1981–1991.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Ostertag, C. B., Trippel, M., Unsöld, R., and Warnke, P. C. (2003). “Therapie der Kraniopharyngeome – Konservatives Vorgehen” in Aktuelle Neuropädiatrie 2002, ed. R. Krointhenberg (Nuremberg: Novartis Pharma Verlag), 43–48.

Pettorini, B. L., Tamburrini, G., Massimi, L., Caldarelli, M., and Di Rocco, C. (2009). Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. J. Neurosurg. Pediatr. 4, 245–248. [Technical note].

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Savas, A., Erdem, A., Tun, K., and Kanpolat, Y. (2000). Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46, 213–216; discussion 216–217.

Pubmed Abstract | Pubmed Full Text

Schubert, T., Trippel, M., Tacke, U., van Velthoven, V., Gumpp, V., Bartelt, S., Ostertag, C., and Nikkhah, G. (2009). Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv. Syst. 25, 1419–1427.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Steňo, J., Bízik, I., Steňo, A., and Matejcík, V. (2011). Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv. Syst. 27, 41–54.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Tian, Z. M., Liu, Z. H., Kang, G. Q., Zhang, Y., Li, S. Y., Chen, X. H., Chui, Y., and Feng, H. (1992). CT-guidedstereotactic injection of radionuclide for treatment of brain tumors. Stereotact. Funct. Neurosurg. 59, 169–173.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Tilgner, J., Herr, M., Ostertag, C., and Volk, B. (2005). Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis – influence of clinical factors. Neurosurgery 56, 257–265.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Veeravagu, A., Lee, M., Jiang, B., and Chang, S. D. (2010). The role of radiosurgery in the treatment of craniopharyngiomas. Neurosurg. Focus 28, E11.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Yaşargil, M. G., Curcic, M., Kis, M., Siegenthaler, G., Teddy, P. J., and Roth, P. (1990). Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J. Neurosurg. 73, 3–11.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhao, R., Deng, J., Liang, X., Zeng, J., Chen, X., and Wang, J. (2010). Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation. Childs Nerv. Syst. 26, 669–674.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Keywords: stereotactic neurosurgery, craniopharyngioma, stereotactic biopsy, internal drainage, cyst puncture, childhood craniopharyngioma, minimal invasive, ventriculocystostomy

Citation: Trippel M and Nikkhah G (2012) Stereotactic neurosurgical treatment options for craniopharyngioma. Front. Endocrin. 3:63. doi: 10.3389/fendo.2012.00063

Received: 30 November 2011; Paper pending published: 10 January 2012;
Accepted: 23 April 2012; Published online: 14 May 2012.

Edited by:

Hermann Lothar Mueller, Klinikum Oldenburg gGmbH, Germany

Reviewed by:

Philippe Chanson, Université Paris-Sud, France
Laurence Katznelson, Stanford University, USA

Copyright: © 2012 Trippel and Nikkhah. This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.

*Correspondence: Michael Trippel, Division of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Breisacher Strasse 64, 79106 Freiburg, Germany. e-mail: michael.trippel@uniklinik-freiburg.de